Strategies Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$266K Sell
9,462
-402
-4% -$10.7K 0.03% 151
2025
Q4
$246K Sell
9,864
-287
-3% -$7.24K 0.02% 165
2025
Q3
$259K Sell
10,151
-235
-2% -$5.8K 0.03% 160
2025
Q2
$252K Buy
10,386
+96
+0.9% +$2.24K 0.03% 159
2025
Q1
$261K Buy
+10,290
New +$269K 0.03% 148

Other funds holding PFE

Strategies Wealth Advisors's PFE Position: Q1 2026 in Review

Strategies Wealth Advisors reduced its Pfizer (PFE) stake by 4.1% in Q1 2026, selling an estimated $10.7K and leaving 9,462 shares worth $266K. The position accounts for 0.03% of the portfolio, ranked #151.

Strategies Wealth Advisors first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Strategies Wealth Advisors held 9,462 shares of Pfizer worth $266K as of Q1 2026.
  • Strategies Wealth Advisors sold 402 Pfizer shares in Q1 2026, an estimated $10.7K.
  • Pfizer made up 0.03% of Strategies Wealth Advisors's portfolio in Q1 2026, its #151 holding.
  • Strategies Wealth Advisors first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Strategies Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.